Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 3713 | 1847 | 33.7 | 76% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CARVEDILOL | Author keyword | 276 | 47% | 23% | 434 |
| 2 | BUCINDOLOL | Author keyword | 12 | 75% | 0% | 9 |
| 3 | CARVEDILOL ENANTIOMERS | Author keyword | 8 | 100% | 0% | 5 |
| 4 | BETA BLOCKADE | Author keyword | 6 | 16% | 2% | 38 |
| 5 | BISOPROLOL | Author keyword | 6 | 15% | 2% | 37 |
| 6 | MERIT HF | Author keyword | 6 | 100% | 0% | 4 |
| 7 | TJ0711 HYDROCHLORIDE | Author keyword | 6 | 100% | 0% | 4 |
| 8 | ALPHA 1 BLOCKADE | Author keyword | 4 | 67% | 0% | 4 |
| 9 | VASODILATING BETA BLOCKER | Author keyword | 4 | 67% | 0% | 4 |
| 10 | SYMPATHETIC VASCULAR ACTIVITY | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CARVEDILOL | 276 | 47% | 23% | 434 | Search CARVEDILOL | Search CARVEDILOL |
| 2 | BUCINDOLOL | 12 | 75% | 0% | 9 | Search BUCINDOLOL | Search BUCINDOLOL |
| 3 | CARVEDILOL ENANTIOMERS | 8 | 100% | 0% | 5 | Search CARVEDILOL+ENANTIOMERS | Search CARVEDILOL+ENANTIOMERS |
| 4 | BETA BLOCKADE | 6 | 16% | 2% | 38 | Search BETA+BLOCKADE | Search BETA+BLOCKADE |
| 5 | BISOPROLOL | 6 | 15% | 2% | 37 | Search BISOPROLOL | Search BISOPROLOL |
| 6 | MERIT HF | 6 | 100% | 0% | 4 | Search MERIT+HF | Search MERIT+HF |
| 7 | TJ0711 HYDROCHLORIDE | 6 | 100% | 0% | 4 | Search TJ0711+HYDROCHLORIDE | Search TJ0711+HYDROCHLORIDE |
| 8 | ALPHA 1 BLOCKADE | 4 | 67% | 0% | 4 | Search ALPHA+1+BLOCKADE | Search ALPHA+1+BLOCKADE |
| 9 | VASODILATING BETA BLOCKER | 4 | 67% | 0% | 4 | Search VASODILATING+BETA+BLOCKER | Search VASODILATING+BETA+BLOCKER |
| 10 | SYMPATHETIC VASCULAR ACTIVITY | 4 | 75% | 0% | 3 | Search SYMPATHETIC+VASCULAR+ACTIVITY | Search SYMPATHETIC+VASCULAR+ACTIVITY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CARVEDILOL | 134 | 28% | 22% | 399 |
| 2 | METOPROLOL | 101 | 24% | 20% | 376 |
| 3 | BUCINDOLOL | 100 | 73% | 4% | 76 |
| 4 | MERIT HF | 63 | 44% | 6% | 108 |
| 5 | RANDOMIZED INTERVENTION TRIAL | 52 | 43% | 5% | 93 |
| 6 | CARDIAC INSUFFICIENCY BISOPROLOL | 48 | 45% | 4% | 80 |
| 7 | BETA ADRENOCEPTOR ANTAGONIST | 47 | 52% | 4% | 65 |
| 8 | BETA BLOCKING DRUG | 38 | 89% | 1% | 17 |
| 9 | DESMETHYL METABOLITE | 37 | 100% | 1% | 14 |
| 10 | ADRENERGIC RECEPTOR BLOCKADE | 30 | 47% | 3% | 47 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| beta-adrenergic receptor blockade in chronic heart failure | 2000 | 582 | 82 | 59% |
| Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol) | 2013 | 26 | 24 | 50% |
| Carvedilol | 1998 | 163 | 60 | 73% |
| Antioxidant activity of carvedilol in cardiovascular disease | 2007 | 55 | 75 | 52% |
| beta-blocker therapy in heart failure - Scientific review | 2002 | 158 | 70 | 50% |
| Treatment of Chronic Heart Failure With beta-Adrenergic Receptor Antagonists A Convergence of Receptor Pharmacology and Clinical Cardiology | 2011 | 35 | 139 | 31% |
| A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure | 2009 | 20 | 58 | 64% |
| Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: Recommendations for patient information | 2013 | 7 | 22 | 68% |
| A Critical Review of the Use of Carvedilol in Ischemic Heart Disease | 2012 | 7 | 62 | 61% |
| Beta-Adrenergic Blockers for Chronic Heart Failure | 2009 | 15 | 30 | 63% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CLIN SCI STUDY OPERAT | 3 | 57% | 0.2% | 4 |
| 2 | CLIN PHARMACOKINET MODELING SIMULAT | 3 | 43% | 0.3% | 6 |
| 3 | MICHIGAN HEART FAILURE TRANSPLANT CARE | 3 | 50% | 0.2% | 4 |
| 4 | CLIN PHARMACOL STAT PROGRAMMING | 2 | 38% | 0.3% | 5 |
| 5 | CARDIOVASC METAB STAT PROGRAMMING | 2 | 67% | 0.1% | 2 |
| 6 | PROMOTE CREAT MED EDUC | 2 | 50% | 0.2% | 3 |
| 7 | PAVIA MED | 2 | 40% | 0.2% | 4 |
| 8 | CLIN TRIALS INVEST UNIT | 1 | 100% | 0.1% | 2 |
| 9 | DATA MANAGEMENT BIOMETRY UNIT | 1 | 100% | 0.1% | 2 |
| 10 | CARDIOVASC METAB MED DEV | 1 | 25% | 0.2% | 4 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000187375 | NEBIVOLOL//VASODILATING BETA BLOCKERS//NEBIVOLOL HYDROCHLORIDE |
| 2 | 0.0000119533 | BISOPROLOL//CARDIOSELECTIVE BETA BLOCKERS//CARDIOSELECTIVE |
| 3 | 0.0000118021 | COLLATERAL CORONARY FLOW//ADV MED TRAINING STATE//BETA BLOCKER |
| 4 | 0.0000105214 | EUROPEAN JOURNAL OF HEART FAILURE//JOURNAL OF CARDIOVASCULAR NURSING//JOURNAL OF CARDIAC FAILURE |
| 5 | 0.0000101085 | T 0509//ZINTEROL//BETA ADRENERGIC RECEPTOR SUBTYPE |
| 6 | 0.0000099558 | ANTIDIABETIC PHARMACOTHERAPY//CHAIR GERIATR SURG//HEART FAILURE INCOR |
| 7 | 0.0000097431 | ZOFENOPRIL//INFARCT EXPANSION//ANGIOTENSIN II AT1 RECEPTOR BLOCKADE |
| 8 | 0.0000092248 | FLOSEQUINAN//BTS 53 554//FIRST DOSE HYPOTENSION |
| 9 | 0.0000088370 | IVABRADINE//RESTING HEART RATE//HOWARD GILMAN HEART VALVE DIS |
| 10 | 0.0000082790 | EXERCISE TL 201 TOMOGRAPHY//NEUROLEPTIC CARDIOMYOPATHY//CARDIOMYOPATHY ISCHEMIC |